- 收听数
- 0
- 性别
- 保密
- 听众数
- 22
- 最后登录
- 2021-6-23
- QQ
 - UID
- 21775
- 阅读权限
- 20
- 帖子
- 967
- 精华
- 0
- 在线时间
- 295 小时
- 注册时间
- 2016-8-26

- 科研币
- 0
- 速递币
- -4873
- 娱乐币
- 152
- 文献值
- 115
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). | 链接 | http://ascopubs.org/doi/abs/10.1200/JCO.2017.74.3062?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed |
10.1200/JCO.2017.74.3062 |
最佳答案
ybdx016 查看完整内容
链接:https://pan.baidu.com/s/15O50QpZHwX5MVr_sFfAZbw 密码:at4i
|